APO Research

APO RESEARCH · REPORT

10-Deacetylbaccatine III

A taxane intermediate supplied as 10-deacetylbaccatin III for separately specified synthesis or research uses.

Product & engineering

Understand the product.

Chemical identity, assay basis, impurities, solvent or carrier and the supplied form determine the material boundary. The substance name and an illustrative container do not establish grade, suitability, handling conditions or a finished-product performance claim.

What turns activity into demand

The selected edition segments 10-Deacetylbaccatine III by ≥95%; ≥98.0%; Others. Its application or channel categories include Production of Docetaxel; Production of Paclitaxel; Others.

The commercial boundary

Read those groups within the selected report’s geography, years and measure. Component, material and finished-system activity should not be combined unless that edition explicitly defines the same commercial scope.

Which composition and supplied-form specification defines the chemical product?

Chemical identity, assay basis, impurities, solvent or carrier and the supplied form determine the material boundary. The substance name and an illustrative container do not establish grade, suitability, handling conditions or a finished-product performance claim. The selected edition’s categories describe its research segmentation; a supplier specification and application-level acceptance test define the particular purchased product.

Technical reading

Selected research

Industry Growth & Trends

Global 10-Deacetylbaccatine III Industry Growth and Trends Forecast to 2032

Market perspective

The global 10-Deacetylbaccatine III market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for 10-Deacetylbaccatine III is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for 10-Deacetylbaccatine III is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for 10-Deacetylbaccatine III is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of 10-Deacetylbaccatine III include Indena, South Pharmaceutical, Sai Phytoceuticals, Sarv Biolabs Pvt, Aphios, Taxus Pharma, Yunnan Hande, Kavya Pharma and Jinhe, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global 10-Deacetylbaccatine III market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The 10-Deacetylbaccatine III market size, estimates, and forecasts are presented in terms of sales volume (t) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global 10-Deacetylbaccatine III market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to 10-Deacetylbaccatine III.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global 10-Deacetylbaccatine III market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

10-Deacetylbaccatine III Market by Company

Indena

South Pharmaceutical

Sai Phytoceuticals

Sarv Biolabs Pvt

Aphios

Taxus Pharma

Yunnan Hande

Kavya Pharma

Jinhe

Phyton Biotech

Deccan Nutraceuticals

Alchem International

10-Deacetylbaccatine III Segment by Type

≥95%

≥98.0%

Others

10-Deacetylbaccatine III Segment by Application

Production of Docetaxel

Production of Paclitaxel

Others

10-Deacetylbaccatine III Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global 10-Deacetylbaccatine III market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of 10-Deacetylbaccatine III and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of 10-Deacetylbaccatine III.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of 10-Deacetylbaccatine III manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of 10-Deacetylbaccatine III in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of ≥95% Table 2. Major Company of ≥98.0% Table 3. Major Company of Others Table 4. Global 10-Deacetylbaccatine III Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global 10-Deacetylbaccatine III Sales by Type (2021-2026) & (t) Table 6. Global 10-Deacetylbaccatine III Sales Market Share in Volume by Type (2021-2026) Table 7. Global 10-Deacetylbaccatine III Sales by Type (2021-2026) & (US$ Million) Table 8. Global 10-Deacetylbaccatine III Sales Market Share in Value by Type (2021-2026) Table 9. Global 10-Deacetylbaccatine III Price by Type (2021-2026) & (USD/t) Table 10. Global 10-Deacetylbaccatine III Sales by Type (2027-2032) & (t) Table 11. Global 10-Deacetylbaccatine III Sales Market Share in Volume by Type (2027-2032) Table 12. Global 10-Deacetylbaccatine III Sales by Type (2027-2032) & (US$ Million) Table 13. Global 10-Deacetylbaccatine III Sales Market Share in Value by Type (2027-2032) Table 14. Global 10-Deacetylbaccatine III Price by Type (2027-2032) & (USD/t) Table 15. North America 10-Deacetylbaccatine III Sales by Type (2021-2026) & (t) Table 16. North America 10-Deacetylbaccatine III Sales by Type (2021-2026) & (US$ Million) Table 17. Europe 10-Deacetylbaccatine III Sales by Type (2021-2026) & (t) Table 18. Europe 10-Deacetylbaccatine III Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific 10-Deacetylbaccatine III Sales by Type (2021-2026) & (t) Table 20. Asia-Pacific 10-Deacetylbaccatine III Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America 10-Deacetylbaccatine III Sales by Type (2021-2026) & (t) Table 22. Latin America 10-Deacetylbaccatine III Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa 10-Deacetylbaccatine III Sales by Type (2021-2026) & (t) Table 24. Middle East and Africa 10-Deacetylbaccatine III Sales by Type (2021-2026) & (US$ Million) Table 25. 10-Deacetylbaccatine III Industry Trends Table 26. 10-Deacetylbaccatine III Industry Drivers Table 27. 10-Deacetylbaccatine III Industry Opportunities and Challenges Table 28. 10-Deacetylbaccatine III Industry Restraints Table 29. Global 10-Deacetylbaccatine III Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global 10-Deacetylbaccatine III Revenue Market Share by Company (2021-2026) Table 31. Global 10-Deacetylbaccatine III Sales by Company (2021-2026) & (t) Table 32. Global 10-Deacetylbaccatine III Sales Share by Company (2021-2026) Table 33. Global 10-Deacetylbaccatine III Market Price by Company (2021-2026) & (USD/t) Table 34. Global 10-Deacetylbaccatine III Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global 10-Deacetylbaccatine III Major Company Production Sites and Headquarters Table 36. Global 10-Deacetylbaccatine III Company, Product Type & Application Table 37. Global 10-Deacetylbaccatine III Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global 10-Deacetylbaccatine III by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global 10-Deacetylbaccatine III Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global 10-Deacetylbaccatine III Sales by Region (2021-2026) & (t) Table 42. Global 10-Deacetylbaccatine III Sales Market Share in Volume by Region (2021-2026) Table 43. Global 10-Deacetylbaccatine III Sales by Region (2021-2026) & (US$ Million) Table 44. Global 10-Deacetylbaccatine III Sales Market Share in Value by Region (2021-2026) Table 45. Global 10-Deacetylbaccatine III Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 46. Global 10-Deacetylbaccatine III Sales by Region (2027-2032) & (t) Table 47. Global 10-Deacetylbaccatine III Sales Market Share in Volume by Region (2027-2032) Table 48. Global 10-Deacetylbaccatine III Sales by Region (2027-2032) & (US$ Million) Table 49. Global 10-Deacetylbaccatine III Sales Market Share in Value by Region (2027-2032) Table 50. Global 10-Deacetylbaccatine III Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2027-2032) Table 51. Global 10-Deacetylbaccatine III Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global 10-Deacetylbaccatine III Sales by Application (2021-2026) & (t) Table 53. Global 10-Deacetylbaccatine III Sales Market Share in Volume by Application (2021-2026) Table 54. Global 10-Deacetylbaccatine III Sales by Application (2021-2026) & (US$ Million) Table 55. Global 10-Deacetylbaccatine III Sales Market Share in Value by Application (2021-2026) Table 56. Global 10-Deacetylbaccatine III Price by Application (2021-2026) & (USD/t) Table 57. Global 10-Deacetylbaccatine III Sales by Application (2027-2032) & (t) Table 58. Global 10-Deacetylbaccatine III Sales Market Share in Volume by Application (2027-2032) Table 59. Global 10-Deacetylbaccatine III Sales by Application (2027-2032) & (US$ Million) Table 60. Global 10-Deacetylbaccatine III Sales Market Share in Value by Application (2027-2032) Table 61. Global 10-Deacetylbaccatine III Price by Application (2027-2032) & (USD/t) Table 62. North America 10-Deacetylbaccatine III Sales by Application (2021-2026) & (t) Table 63. North America 10-Deacetylbaccatine III Sales by Application (2021-2026) & (US$ Million) Table 64. Europe 10-Deacetylbaccatine III Sales by Application (2021-2026) & (t) Table 65. Europe 10-Deacetylbaccatine III Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific 10-Deacetylbaccatine III Sales by Application (2021-2026) & (t) Table 67. Asia-Pacific 10-Deacetylbaccatine III Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America 10-Deacetylbaccatine III Sales by Application (2021-2026) & (t) Table 69. Latin America 10-Deacetylbaccatine III Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa 10-Deacetylbaccatine III Sales by Application (2021-2026) & (t) Table 71. Middle East and Africa 10-Deacetylbaccatine III Sales by Application (2021-2026) & (US$ Million) Table 72. Indena Company Information Table 73. Indena Business Overview Table 74. Indena 10-Deacetylbaccatine III Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 75. Indena 10-Deacetylbaccatine III Product Portfolio Table 76. Indena Recent Development Table 77. South Pharmaceutical Company Information Table 78. South Pharmaceutical Business Overview Table 79. South Pharmaceutical 10-Deacetylbaccatine III Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 80. South Pharmaceutical 10-Deacetylbaccatine III Product Portfolio Table 81. South Pharmaceutical Recent Development Table 82. Sai Phytoceuticals Company Information Table 83. Sai Phytoceuticals Business Overview Table 84. Sai Phytoceuticals 10-Deacetylbaccatine III Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 85. Sai Phytoceuticals 10-Deacetylbaccatine III Product Portfolio Table 86. Sai Phytoceuticals Recent Development Table 87. Sarv Biolabs Pvt Company Information Table 88. Sarv Biolabs Pvt Business Overview Table 89. Sarv Biolabs Pvt 10-Deacetylbaccatine III Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 90. Sarv Biolabs Pvt 10-Deacetylbaccatine III Product Portfolio Table 91. Sarv Biolabs Pvt Recent Development Table 92. Aphios Company Information Table 93. Aphios Business Overview Table 94. Aphios 10-Deacetylbaccatine III Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 95. Aphios 10-Deacetylbaccatine III Product Portfolio Table 96. Aphios Recent Development Table 97. Taxus Pharma Company Information Table 98. Taxus Pharma Business Overview Table 99. Taxus Pharma 10-Deacetylbaccatine III Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 100. Taxus Pharma 10-Deacetylbaccatine III Product Portfolio Table 101. Taxus Pharma Recent Development Table 102. Yunnan Hande Company Information Table 103. Yunnan Hande Business Overview Table 104. Yunnan Hande 10-Deacetylbaccatine III Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 105. Yunnan Hande 10-Deacetylbaccatine III Product Portfolio Table 106. Yunnan Hande Recent Development Table 107. Kavya Pharma Company Information Table 108. Kavya Pharma Business Overview Table 109. Kavya Pharma 10-Deacetylbaccatine III Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 110. Kavya Pharma 10-Deacetylbaccatine III Product Portfolio Table 111. Kavya Pharma Recent Development Table 112. Jinhe Company Information Table 113. Jinhe Business Overview Table 114. Jinhe 10-Deacetylbaccatine III Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 115. Jinhe 10-Deacetylbaccatine III Product Portfolio Table 116. Jinhe Recent Development Table 117. Phyton Biotech Company Information Table 118. Phyton Biotech Business Overview Table 119. Phyton Biotech 10-Deacetylbaccatine III Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 120. Phyton Biotech 10-Deacetylbaccatine III Product Portfolio Table 121. Phyton Biotech Recent Development Table 122. Deccan Nutraceuticals Company Information Table 123. Deccan Nutraceuticals Business Overview Table 124. Deccan Nutraceuticals 10-Deacetylbaccatine III Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 125. Deccan Nutraceuticals 10-Deacetylbaccatine III Product Portfolio Table 126. Deccan Nutraceuticals Recent Development Table 127. Alchem International Company Information Table 128. Alchem International Business Overview Table 129. Alchem International 10-Deacetylbaccatine III Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 130. Alchem International 10-Deacetylbaccatine III Product Portfolio Table 131. Alchem International Recent Development Table 132. North America 10-Deacetylbaccatine III Market Size Growth Rate (CAGR) by Country (t): 2021 VS 2025 VS 2032 Table 133. North America 10-Deacetylbaccatine III Sales by Country (2021-2026) & (t) Table 134. North America 10-Deacetylbaccatine III Sales Market Share by Country (2021-2026) Table 135. North America 10-Deacetylbaccatine III Sales Forecast by Country (2027-2032) & (t) Table 136. North America 10-Deacetylbaccatine III Sales Market Share Forecast by Country (2027-2032) Table 137. North America 10-Deacetylbaccatine III Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 138. North America 10-Deacetylbaccatine III Market Size by Country (2021-2026) & (US$ Million) Table 139. North America 10-Deacetylbaccatine III Market Share by Country (2021-2026) Table 140. North America 10-Deacetylbaccatine III Market Size Forecast by Country (2027-2032) & (US$ Million) Table 141. North America 10-Deacetylbaccatine III Market Share Forecast by Country (2027-2032) Table 142. Europe 10-Deacetylbaccatine III Market Size Growth Rate (CAGR) by Country (t): 2021 VS 2025 VS 2032 Table 143. Europe 10-Deacetylbaccatine III Sales by Country (2021-2026) & (t) Table 144. Europe 10-Deacetylbaccatine III Sales Market Share by Country (2021-2026) Table 145. Europe 10-Deacetylbaccatine III Sales Forecast by Country (2027-2032) & (t) Table 146. Europe 10-Deacetylbaccatine III Sales Market Share Forecast by Country (2027-2032) Table 147. Europe 10-Deacetylbaccatine III Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 148. Europe 10-Deacetylbaccatine III Market Size by Country (2021-2026) & (US$ Million) Table 149. Europe 10-Deacetylbaccatine III Market Share by Country (2021-2026) Table 150. Europe 10-Deacetylbaccatine III Market Size Forecast by Country (2027-2032) & (US$ Million) Table 151. Europe 10-Deacetylbaccatine III Market Share Forecast by Country (2027-2032) Table 152. Asia-Pacific 10-Deacetylbaccatine III Market Size Growth Rate (CAGR) by Country (t): 2021 VS 2025 VS 2032 Table 153. Asia-Pacific 10-Deacetylbaccatine III Sales by Country (2021-2026) & (t) Table 154. Asia-Pacific 10-Deacetylbaccatine III Sales Market Share by Country (2021-2026) Table 155. Asia-Pacific 10-Deacetylbaccatine III Sales Forecast by Country (2027-2032) & (t) Table 156. Asia-Pacific 10-Deacetylbaccatine III Sales Market Share Forecast by Country (2027-2032) Table 157. Asia-Pacific 10-Deacetylbaccatine III Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 158. Asia-Pacific 10-Deacetylbaccatine III Market Size by Country (2021-2026) & (US$ Million) Table 159. Asia-Pacific 10-Deacetylbaccatine III Market Share by Country (2021-2026) Table 160. Asia-Pacific 10-Deacetylbaccatine III Market Size Forecast by Country (2027-2032) & (US$ Million) Table 161. Asia-Pacific 10-Deacetylbaccatine III Market Share Forecast by Country (2027-2032) Table 162. Latin America 10-Deacetylbaccatine III Market Size Growth Rate (CAGR) by Country (t): 2021 VS 2025 VS 2032 Table 163. Latin America 10-Deacetylbaccatine III Sales by Country (2021-2026) & (t) Table 164. Latin America 10-Deacetylbaccatine III Sales Market Share by Country (2021-2026) Table 165. Latin America 10-Deacetylbaccatine III Sales Forecast by Country (2027-2032) & (t) Table 166. Latin America 10-Deacetylbaccatine III Sales Market Share Forecast by Country (2027-2032) Table 167. Latin America 10-Deacetylbaccatine III Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 168. Latin America 10-Deacetylbaccatine III Market Size by Country (2021-2026) & (US$ Million) Table 169. Latin America 10-Deacetylbaccatine III Market Share by Country (2021-2026) Table 170. Latin America 10-Deacetylbaccatine III Market Size Forecast by Country (2027-2032) & (US$ Million) Table 171. Latin America 10-Deacetylbaccatine III Market Share Forecast by Country (2027-2032) Table 172. Middle East and Africa 10-Deacetylbaccatine III Market Size Growth Rate (CAGR) by Country (t): 2021 VS 2025 VS 2032 Table 173. Middle East and Africa 10-Deacetylbaccatine III Sales by Country (2021-2026) & (t) Table 174. Middle East and Africa 10-Deacetylbaccatine III Sales Market Share by Country (2021-2026) Table 175. Middle East and Africa 10-Deacetylbaccatine III Sales Forecast by Country (2027-2032) & (t) Table 176. Middle East and Africa 10-Deacetylbaccatine III Sales Market Share Forecast by Country (2027-2032) Table 177. Middle East and Africa 10-Deacetylbaccatine III Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 178. Middle East and Africa 10-Deacetylbaccatine III Market Size by Country (2021-2026) & (US$ Million) Table 179. Middle East and Africa 10-Deacetylbaccatine III Market Share by Country (2021-2026) Table 180. Middle East and Africa 10-Deacetylbaccatine III Market Size Forecast by Country (2027-2032) & (US$ Million) Table 181. Middle East and Africa 10-Deacetylbaccatine III Market Share Forecast by Country (2027-2032) Table 182. Key Raw Materials Table 183. Raw Materials Key Suppliers Table 184. 10-Deacetylbaccatine III Distributors List Table 185. 10-Deacetylbaccatine III Customers List Table 186. Research Programs/Design for This Report Table 187. Authors List of This Report Table 188. Secondary Sources Table 189. Primary Sources List of Figures Figure 1. 10-Deacetylbaccatine III Image Figure 2. Global 10-Deacetylbaccatine III Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global 10-Deacetylbaccatine III Market Size (2021-2032) & (US$ Million) Figure 4. Global 10-Deacetylbaccatine III Sales (2021-2032) & (t) Figure 5. ≥95% Image Figure 6. Global ≥95% Sales YoY Growth (2021-2032) & (t) Figure 7. ≥98.0% Image Figure 8. Global ≥98.0% Sales YoY Growth (2021-2032) & (t) Figure 9. Others Image Figure 10. Global Others Sales YoY Growth (2021-2032) & (t) Figure 11. Global 10-Deacetylbaccatine III Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global 10-Deacetylbaccatine III Market Share by Type 2025 VS 2032 Figure 13. North America 10-Deacetylbaccatine III Sales Market Share in Volume by Type in 2025 Figure 14. North America 10-Deacetylbaccatine III Sales Market Share in Value by Type in 2025 Figure 15. Europe 10-Deacetylbaccatine III Sales Market Share in Volume by Type in 2025 Figure 16. Europe 10-Deacetylbaccatine III Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific 10-Deacetylbaccatine III Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific 10-Deacetylbaccatine III Sales Market Share in Value by Type in 2025 Figure 19. Latin America 10-Deacetylbaccatine III Sales Market Share in Volume by Type in 2025 Figure 20. Latin America 10-Deacetylbaccatine III Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa 10-Deacetylbaccatine III Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa 10-Deacetylbaccatine III Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 10-Deacetylbaccatine III Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Production of Docetaxel Image Figure 26. Global Production of Docetaxel Sales YoY Growth (2021-2032) & (t) Figure 27. Production of Paclitaxel Image Figure 28. Global Production of Paclitaxel Sales YoY Growth (2021-2032) & (t) Figure 29. Others Image Figure 30. Global Others Sales YoY Growth (2021-2032) & (t) Figure 31. Global 10-Deacetylbaccatine III Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global 10-Deacetylbaccatine III Market Share by Application 2025 VS 2032 Figure 33. North America 10-Deacetylbaccatine III Sales Market Share in Volume by Application in 2025 Figure 34. North America 10-Deacetylbaccatine III Sales Market Share in Value by Application in 2025 Figure 35. Europe 10-Deacetylbaccatine III Sales Market Share in Volume by Application in 2025 Figure 36. Europe 10-Deacetylbaccatine III Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific 10-Deacetylbaccatine III Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific 10-Deacetylbaccatine III Sales Market Share in Value by Application in 2025 Figure 39. Latin America 10-Deacetylbaccatine III Sales Market Share in Volume by Application in 2025 Figure 40. Latin America 10-Deacetylbaccatine III Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa 10-Deacetylbaccatine III Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa 10-Deacetylbaccatine III Sales Market Share in Value by Application in 2025 Figure 43. North America 10-Deacetylbaccatine III Sales by Country: 2021 VS 2025 VS 2032 (t) Figure 44. North America 10-Deacetylbaccatine III Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America 10-Deacetylbaccatine III Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America 10-Deacetylbaccatine III Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe 10-Deacetylbaccatine III Sales by Country: 2021 VS 2025 VS 2032 (t) Figure 48. Europe 10-Deacetylbaccatine III Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe 10-Deacetylbaccatine III Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe 10-Deacetylbaccatine III Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific 10-Deacetylbaccatine III Sales by Country: 2021 VS 2025 VS 2032 (t) Figure 52. Asia-Pacific 10-Deacetylbaccatine III Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific 10-Deacetylbaccatine III Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific 10-Deacetylbaccatine III Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America 10-Deacetylbaccatine III Sales by Country: 2021 VS 2025 VS 2032 (t) Figure 56. Latin America 10-Deacetylbaccatine III Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America 10-Deacetylbaccatine III Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America 10-Deacetylbaccatine III Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa 10-Deacetylbaccatine III Sales by Country: 2021 VS 2025 VS 2032 (t) Figure 60. Middle East and Africa 10-Deacetylbaccatine III Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa 10-Deacetylbaccatine III Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa 10-Deacetylbaccatine III Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. 10-Deacetylbaccatine III Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. 10-Deacetylbaccatine III Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • ≥95%
  • ≥98.0%
  • Others
Applications
  • Production of Docetaxel
  • Production of Paclitaxel
  • Others
Companies covered
  • Indena
  • South Pharmaceutical
  • Sai Phytoceuticals
  • Sarv Biolabs Pvt
  • Aphios
  • Taxus Pharma
  • Yunnan Hande
  • Kavya Pharma
  • Jinhe
  • Phyton Biotech
  • Deccan Nutraceuticals
  • Alchem International

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global 10-Deacetylbaccatine III Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global 10-Deacetylbaccatine III Sales Estimates and Forecasts (2021-2032)
  5. 1.3 10-Deacetylbaccatine III Market by Type
  6. 1.3.1 ≥95%
  7. 1.3.2 ≥98.0%
  8. 1.3.3 Others
  9. 1.4 Global 10-Deacetylbaccatine III Market Size by Type
  10. 1.4.1 Global 10-Deacetylbaccatine III Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global 10-Deacetylbaccatine III Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global 10-Deacetylbaccatine III Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America 10-Deacetylbaccatine III Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe 10-Deacetylbaccatine III Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific 10-Deacetylbaccatine III Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America 10-Deacetylbaccatine III Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa 10-Deacetylbaccatine III Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 10-Deacetylbaccatine III Industry Trends
  2. 2.2 10-Deacetylbaccatine III Industry Drivers
  3. 2.3 10-Deacetylbaccatine III Industry Opportunities and Challenges
  4. 2.4 10-Deacetylbaccatine III Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by 10-Deacetylbaccatine III Revenue (2021-2026)
  2. 3.2 Global Top Players by 10-Deacetylbaccatine III Sales (2021-2026)
  3. 3.3 Global Top Players by 10-Deacetylbaccatine III Price (2021-2026)
  4. 3.4 Global 10-Deacetylbaccatine III Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global 10-Deacetylbaccatine III Major Company Production Sites & Headquarters
  6. 3.6 Global 10-Deacetylbaccatine III Company, Product Type & Application
  7. 3.7 Global 10-Deacetylbaccatine III Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global 10-Deacetylbaccatine III Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 10-Deacetylbaccatine III Players Market Share by Revenue in 2025
  11. 3.8.3 2025 10-Deacetylbaccatine III Tier 1, Tier 2, and Tier 3
4 10-Deacetylbaccatine III Regional Status and Outlook
  1. 4.1 Global 10-Deacetylbaccatine III Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global 10-Deacetylbaccatine III Historic Market Size by Region
  3. 4.2.1 Global 10-Deacetylbaccatine III Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global 10-Deacetylbaccatine III Sales in Value by Region (2021-2026)
  5. 4.2.3 Global 10-Deacetylbaccatine III Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global 10-Deacetylbaccatine III Forecasted Market Size by Region
  7. 4.3.1 Global 10-Deacetylbaccatine III Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global 10-Deacetylbaccatine III Sales in Value by Region (2027-2032)
  9. 4.3.3 Global 10-Deacetylbaccatine III Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 10-Deacetylbaccatine III by Application
  1. 5.1 10-Deacetylbaccatine III Market by Application
  2. 5.1.1 Production of Docetaxel
  3. 5.1.2 Production of Paclitaxel
  4. 5.1.3 Others
  5. 5.2 Global 10-Deacetylbaccatine III Market Size by Application
  6. 5.2.1 Global 10-Deacetylbaccatine III Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global 10-Deacetylbaccatine III Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global 10-Deacetylbaccatine III Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America 10-Deacetylbaccatine III Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe 10-Deacetylbaccatine III Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific 10-Deacetylbaccatine III Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America 10-Deacetylbaccatine III Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa 10-Deacetylbaccatine III Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Indena
  2. 6.1.1 Indena Company Information
  3. 6.1.2 Indena Business Overview
  4. 6.1.3 Indena 10-Deacetylbaccatine III Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Indena 10-Deacetylbaccatine III Product Portfolio
  6. 6.1.5 Indena Recent Developments
  7. 6.2 South Pharmaceutical
  8. 6.2.1 South Pharmaceutical Company Information
  9. 6.2.2 South Pharmaceutical Business Overview
  10. 6.2.3 South Pharmaceutical 10-Deacetylbaccatine III Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 South Pharmaceutical 10-Deacetylbaccatine III Product Portfolio
  12. 6.2.5 South Pharmaceutical Recent Developments
  13. 6.3 Sai Phytoceuticals
  14. 6.3.1 Sai Phytoceuticals Company Information
  15. 6.3.2 Sai Phytoceuticals Business Overview
  16. 6.3.3 Sai Phytoceuticals 10-Deacetylbaccatine III Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Sai Phytoceuticals 10-Deacetylbaccatine III Product Portfolio
  18. 6.3.5 Sai Phytoceuticals Recent Developments
  19. 6.4 Sarv Biolabs Pvt
  20. 6.4.1 Sarv Biolabs Pvt Company Information
  21. 6.4.2 Sarv Biolabs Pvt Business Overview
  22. 6.4.3 Sarv Biolabs Pvt 10-Deacetylbaccatine III Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Sarv Biolabs Pvt 10-Deacetylbaccatine III Product Portfolio
  24. 6.4.5 Sarv Biolabs Pvt Recent Developments
  25. 6.5 Aphios
  26. 6.5.1 Aphios Company Information
  27. 6.5.2 Aphios Business Overview
  28. 6.5.3 Aphios 10-Deacetylbaccatine III Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Aphios 10-Deacetylbaccatine III Product Portfolio
  30. 6.5.5 Aphios Recent Developments
  31. 6.6 Taxus Pharma
  32. 6.6.1 Taxus Pharma Company Information
  33. 6.6.2 Taxus Pharma Business Overview
  34. 6.6.3 Taxus Pharma 10-Deacetylbaccatine III Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Taxus Pharma 10-Deacetylbaccatine III Product Portfolio
  36. 6.6.5 Taxus Pharma Recent Developments
  37. 6.7 Yunnan Hande
  38. 6.7.1 Yunnan Hande Company Information
  39. 6.7.2 Yunnan Hande Business Overview
  40. 6.7.3 Yunnan Hande 10-Deacetylbaccatine III Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Yunnan Hande 10-Deacetylbaccatine III Product Portfolio
  42. 6.7.5 Yunnan Hande Recent Developments
  43. 6.8 Kavya Pharma
  44. 6.8.1 Kavya Pharma Company Information
  45. 6.8.2 Kavya Pharma Business Overview
  46. 6.8.3 Kavya Pharma 10-Deacetylbaccatine III Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Kavya Pharma 10-Deacetylbaccatine III Product Portfolio
  48. 6.8.5 Kavya Pharma Recent Developments
  49. 6.9 Jinhe
  50. 6.9.1 Jinhe Company Information
  51. 6.9.2 Jinhe Business Overview
  52. 6.9.3 Jinhe 10-Deacetylbaccatine III Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Jinhe 10-Deacetylbaccatine III Product Portfolio
  54. 6.9.5 Jinhe Recent Developments
  55. 6.10 Phyton Biotech
  56. 6.10.1 Phyton Biotech Company Information
  57. 6.10.2 Phyton Biotech Business Overview
  58. 6.10.3 Phyton Biotech 10-Deacetylbaccatine III Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Phyton Biotech 10-Deacetylbaccatine III Product Portfolio
  60. 6.10.5 Phyton Biotech Recent Developments
  61. 6.11 Deccan Nutraceuticals
  62. 6.11.1 Deccan Nutraceuticals Company Information
  63. 6.11.2 Deccan Nutraceuticals Business Overview
  64. 6.11.3 Deccan Nutraceuticals 10-Deacetylbaccatine III Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Deccan Nutraceuticals 10-Deacetylbaccatine III Product Portfolio
  66. 6.11.5 Deccan Nutraceuticals Recent Developments
  67. 6.12 Alchem International
  68. 6.12.1 Alchem International Company Information
  69. 6.12.2 Alchem International Business Overview
  70. 6.12.3 Alchem International 10-Deacetylbaccatine III Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Alchem International 10-Deacetylbaccatine III Product Portfolio
  72. 6.12.5 Alchem International Recent Developments
7 North America by Country
  1. 7.1 North America 10-Deacetylbaccatine III Sales by Country
  2. 7.1.1 North America 10-Deacetylbaccatine III Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America 10-Deacetylbaccatine III Sales by Country (2021-2026)
  4. 7.1.3 North America 10-Deacetylbaccatine III Sales Forecast by Country (2027-2032)
  5. 7.2 North America 10-Deacetylbaccatine III Market Size by Country
  6. 7.2.1 North America 10-Deacetylbaccatine III Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America 10-Deacetylbaccatine III Market Size by Country (2021-2026)
  8. 7.2.3 North America 10-Deacetylbaccatine III Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe 10-Deacetylbaccatine III Sales by Country
  2. 8.1.1 Europe 10-Deacetylbaccatine III Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe 10-Deacetylbaccatine III Sales by Country (2021-2026)
  4. 8.1.3 Europe 10-Deacetylbaccatine III Sales Forecast by Country (2027-2032)
  5. 8.2 Europe 10-Deacetylbaccatine III Market Size by Country
  6. 8.2.1 Europe 10-Deacetylbaccatine III Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe 10-Deacetylbaccatine III Market Size by Country (2021-2026)
  8. 8.2.3 Europe 10-Deacetylbaccatine III Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific 10-Deacetylbaccatine III Sales by Country
  2. 9.1.1 Asia-Pacific 10-Deacetylbaccatine III Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific 10-Deacetylbaccatine III Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific 10-Deacetylbaccatine III Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific 10-Deacetylbaccatine III Market Size by Country
  6. 9.2.1 Asia-Pacific 10-Deacetylbaccatine III Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific 10-Deacetylbaccatine III Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific 10-Deacetylbaccatine III Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America 10-Deacetylbaccatine III Sales by Country
  2. 10.1.1 South America 10-Deacetylbaccatine III Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America 10-Deacetylbaccatine III Sales by Country (2021-2026)
  4. 10.1.3 South America 10-Deacetylbaccatine III Sales Forecast by Country (2027-2032)
  5. 10.2 South America 10-Deacetylbaccatine III Market Size by Country
  6. 10.2.1 South America 10-Deacetylbaccatine III Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America 10-Deacetylbaccatine III Market Size by Country (2021-2026)
  8. 10.2.3 South America 10-Deacetylbaccatine III Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa 10-Deacetylbaccatine III Sales by Country
  2. 11.1.1 Middle East and Africa 10-Deacetylbaccatine III Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa 10-Deacetylbaccatine III Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa 10-Deacetylbaccatine III Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa 10-Deacetylbaccatine III Market Size by Country
  6. 11.2.1 Middle East and Africa 10-Deacetylbaccatine III Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa 10-Deacetylbaccatine III Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa 10-Deacetylbaccatine III Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 10-Deacetylbaccatine III Value Chain Analysis
  2. 12.1.1 10-Deacetylbaccatine III Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 10-Deacetylbaccatine III Production Mode & Process
  7. 12.2 10-Deacetylbaccatine III Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 10-Deacetylbaccatine III Distributors
  10. 12.2.3 10-Deacetylbaccatine III Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research